Schuman v. Muller

484 F. Supp. 1334, 1980 U.S. Dist. LEXIS 10245
CourtDistrict Court, E.D. Pennsylvania
DecidedMarch 3, 1980
DocketCiv. A. 79-4321
StatusPublished
Cited by1 cases

This text of 484 F. Supp. 1334 (Schuman v. Muller) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Schuman v. Muller, 484 F. Supp. 1334, 1980 U.S. Dist. LEXIS 10245 (E.D. Pa. 1980).

Opinion

OPINION

LUONGO, District Judge.

The Pennsylvania Generic Drug Act (Act), 35 Pa.Stat.Ann. §§ 960.1-.7 (Purdon 1977), has as its objective the delivery of prescription drugs to consumers at the lowest possible cost. See generally id. § 960.1. To this end, the Act authorizes a pharmacist to substitute a less expensive generically equivalent drug for the brand name drug prescribed if the prescription specifically permits substitution and the purchaser acquiesces. See generally id. § 960.3(A). The Act, however, limits the generic drugs that may be substituted to those drugs listed in the formulary developed by the Pennsylvania Department of Health. See generally id. § 960.3(A), (F).

This action, filed on November 29, 1979, by a pharmacist and his retail drug chain, challenges the constitutionality of the generic drug law. Plaintiffs allege, inter alia, that the definition of “generically equivalent drug” in section 960.2 of the Act is unconstitutionally vague; that the determination of equivalence by the state Secretary of Health and the resultant omission from or inclusion of certain drugs on the state drug formulary is arbitrary and capricious; that the exception in section 960.6(C) for hospital pharmacies who have developed their own formularies denies plaintiffs equal protection of the law; that Congress *1335 has, through the Food, Drug and Cosmetic Act, 21 U.S.C. §§ 301-392 (1976 & Supp. II 1978), which authorizes the FDA to publish a national formulary, preempted state regulation in this area; and that including in the formulary distributors named by manufacturers of approved drugs while excluding therefrom distributors of the identical product not named by the manufacturers creates a de facto monopoly.

Plaintiffs presently seek a preliminary injunction against enforcement of the Act. At the hearing on plaintiffs’ motion for preliminary relief, I inquired whether plaintiffs’ voluntary agreement to comply with the Act (properly termed an assurance of voluntary compliance), which had been executed on October 31, 1979, and filed with the Montgomery County court of common pleas, implicated the abstention principles of Younger v. Harris, 401 U.S. 37, 91 S.Ct. 746, 27 L.Ed.2d 669 (1971), and its progeny. Plaintiffs requested time to brief the question, and I afforded both parties the opportunity to submit additional memoranda on this threshold issue. After careful consideration of the arguments advanced in those memoranda, I conclude that the Younger doctrine counsels against the exercise of jurisdiction in this case.

Plaintiff Schuman, a licensed pharmacist, is the president and sole shareholder of plaintiff corporation, I. Schuman Industries, Inc., which is engaged in the retail distribution and sale of pharmaceutical products in the commonwealth. Complaint (Doc. No. 1) ¶¶ 3-4. Sometime in the latter part of 1979, the Pennsylvania Bureau of Consumer Protection conducted an investigation into plaintiffs’ business practices. That investigation revealed inter alia that plaintiffs were dispensing as generic equivalents drugs not listed in the Pennsylvania drug formulary. Id., Exhibit A at 2-3. As a corrective measure, the Commonwealth agreed to accept an assurance of voluntary compliance from plaintiffs, rather than file a civil suit seeking an injunction against future violations. Id., Exhibit A at 3. Compare 73 Pa.Stat.Ann. § 201-4 (Purdon Supp.1979-1980) (injunction against prohibited acts) with id. § 201-5 (assurance of voluntary compliance). By executing the assurance, plaintiffs agreed to comply with the Act in future, although they did not admit any past violation or wrongdoing. Complaint (Doc. No. 1), Exhibit A at 5. The assurance was filed with the Court of Common Pleas for Montgomery County on October 31, 1979, and by the terms of the agreement, that court retains “jurisdiction over the subject matter of this Assurance and over Respondents for the purpose, of enforcement of this Assurance pursuant to the Act.” Id., Exhibit A, IF at 4. The agreement also provides that “breach of any or all of the terms of this Assurance of Voluntary Compliance shall be sufficient warrant for the Commonwealth of Pennsylvania to petition the Court of Common Pleas of Montgomery County to assess civil penalties and to order any other equitable relief which the Court deems necessary or proper . . . .” Id., Exhibit A at 5.

Defendants urge that the strand of the abstention doctrine rooted in Younger v. Harris, supra, 401 U.S. 37, 91 S.Ct. 746, 27 L.Ed.2d 669, dictates dismissal of the instant action. Younger and its companion case, Samuels v. Mackell, 401 U.S. 66, 91 S.Ct. 764, 27 L.Ed.2d 688 (1971), preclude a federal district court from issuing either an injunction against enforcement of a state statute or a declaration of the statute’s invalidity when a state criminal prosecution is pending against the federal plaintiff, absent a showing of harassment or bad faith on the part of state officials, or great and immediate irreparable injury to the federal plaintiff. Later cases have extended Younger abstention to pending civil proceedings brought to vindicate important state interests. Huffman v. Pursue, Ltd., 420 U.S. 592, 95 S.Ct. 1200, 43 L.Ed.2d 482 (1975) (public nuisance statute); accord, Moore v. Sims, 442 U.S. 415, 99 S.Ct. 2371, 60 L.Ed.2d 994 (1979) (proceeding under Texas Family Code to remove abused children from parental custody); Trainor v. Hernandez, 431 U.S. 434, 97 S.Ct. 1911, 52 L.Ed.2d 486 (1977) (civil attachment proceeding to recover welfare payments fraudulently received); Juidice v. Vail, 430 U.S. *1336 327, 97 S.Ct. 1211, 51 L.Ed.2d 376 (1977) (state contempt proceedings).

Plaintiffs argue that the Younger doctrine is inapplicable to the case at bar because there is no enforcement action currently pending in state court. Indeed, they contend that inasmuch as no formal pleadings against them were ever filed by the Attorney General, there was never any action pending against them to trigger Younger abstention. Downplaying the provision in the assurance of voluntary compliance that vests continuing jurisdiction in the court of common pleas, plaintiffs suggest that the assurance signaled both the beginning and the end of the matter. They aver that their conduct presently conforms to the requirements of the generic drug law. Proceeding from this premise, they argue that the state court’s jurisdiction is, at best, a technicality because there is no ongoing illegal conduct to precipitate further action in state court.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Adams v. Supreme Court of Pennsylvania
502 F. Supp. 1282 (M.D. Pennsylvania, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
484 F. Supp. 1334, 1980 U.S. Dist. LEXIS 10245, Counsel Stack Legal Research, https://law.counselstack.com/opinion/schuman-v-muller-paed-1980.